معرفی
Oliver David Kenneth Maddocks is a Cancer Research UK (CRUK) Research Fellow and Group Leader at the University of Glasgow's School of Cancer Sciences. He holds an ORCID identifier 0000-0002-5551-9091 and can be contacted at Oliver.Maddocks@glasgow.ac.uk.
- MPharm (2003) from Cardiff University
- PhD (2008) at University of Edinburgh
His research focuses on cancer metabolism, particularly how cancer cells acquire and utilize nutrients like serine and glycine, and how metabolic by-products influence tumor growth and therapy response. Key areas include:
- Targeting nutrient availability to impede tumor proliferation
- Metabolic interactions between tumor and stromal cells
- Exploiting metabolic vulnerabilities for therapeutic interventions
- Developing PET imaging techniques to monitor tumor metabolism
His recent work spans 2023–2025 publications in high-impact journals like Nature Metabolism and Cancer and Metabolism, addressing topics such as serine transport, mitochondrial stress, and metabolic drivers of drug resistance.
- 2016 British Association for Cancer Research AstraZeneca/Frank Rose Young Scientist Prize
- 2019–2021 Mattia Falcone Fellowship (EMBO)
Grants include funding from CRUK, Blood Cancer UK, and Children with Cancer UK (2018–2024), targeting metabolic therapies in colorectal, pancreatic, and neuroblastoma cancers.
